A collaborative design NGS panel targeting clinically actionable mutations across cancer types. Designed to identify mutations with therapeutic implications for treatment guidance. Available as a pre-designed panel for immediate implementation.
Manufactured by
United Kingdom
Nonacus is a UK-based leader in precision oncology, transforming how cancer is detected and managed. Headquartered in Birmingham and working with scientists and clinicians worldwide, we are building an end-to-end genetic testing workflow designed to make early cancer detection simpler, faster, and more accessible.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Burning Rock Dx Co. Ltd.
China · 3 relevant products
Genes 2Me Private Ltd
India · 5 relevant products
Biopsense Oy
Finland · 1 relevant product
Wuhan YZY Medical Science and Technology Co.,Ltd.
China · 4 relevant products
YouSeq
United Kingdom · 2 relevant products
3B BlackBio Dx - TRUPCR Europe - CORIS BioConcept
India · 3 relevant products
BioChain (Beijing) Science & Technology. Inc.
China · 1 relevant product
TRUPCR Europe Ltd
United Kingdom · 8 relevant products
Medicover Genetics Ltd
Cyprus · 4 relevant products
Cygnus Biosciences (Beijing)Co., Ltd.
China · 1 relevant product
38 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →6 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 91 closest product alternatives
Burning Rock Dx Co. Ltd. · China
Focused testing panel targeting common cancer-associated mutations for rapid diagnostic confirmation. Provides quick results for urgent treatment decisions.
Genes 2Me Private Ltd · India
Genomic sequencing panel for cancer-related mutation and biomarker detection. Supports precision oncology treatment planning and selection.
Burning Rock Dx Co. Ltd. · China
Next-generation sequencing panel for comprehensive cancer genomic profiling. Identifies mutations, copy number variations, and other genetic alterations to guide personalized treatment strategies.
Biopsense Oy · Finland
Blood test panel for detecting and characterizing genetic and epigenetic mutations in circulating tumor DNA. Helps determine cancer origin, measure tumor burden, and identify new mutations during targeted therapy treatment.
Wuhan YZY Medical Science and Technology Co.,Ltd. · China
Comprehensive diagnostic panel for personalized treatment selection in cardiovascular and oncology diseases. Analyzes multiple genetic and molecular markers to guide clinical decision-making.
YouSeq · United Kingdom
An NGS-based panel for detection of inherited genetic mutations associated with hereditary cancer syndromes. Enables identification of cancer predisposition for risk stratification and preventive clinical decision-making.
3B BlackBio Dx - TRUPCR Europe - CORIS BioConcept · India
Diagnostic kit for detecting relevant mutations in colorectal cancer tissue samples. Identifies mutations affecting prognosis and treatment selection.
BioChain (Beijing) Science & Technology. Inc. · China
Next-generation sequencing-based multiplex cancer screening panel for simultaneous detection of multiple cancer types. This advanced molecular diagnostic test enables comprehensive cancer risk stratification from single blood samples. The product is in development as part of the company's precision oncology pipeline.
TRUPCR Europe Ltd · United Kingdom
A diagnostic test kit designed to detect mutations associated with colorectal cancer. This panel enables identification of genetic alterations relevant to colorectal cancer diagnosis and management.
3B BlackBio Dx - TRUPCR Europe - CORIS BioConcept · India
Targeted diagnostic panel for detecting mutations and fusion genes in acute lymphoblastic leukemia. Supports prognostic stratification and identification of therapeutic targets.
Medicover Genetics Ltd · Cyprus
Genetic testing for cancer predisposition and somatic cancer variants to identify individuals at risk or with diagnosed malignancies. Includes comprehensive sequencing with clinical validation and genetic counselling.
TRUPCR Europe Ltd · United Kingdom
A diagnostic test kit for detecting mutations associated with lung cancer. This panel identifies genetic alterations relevant to lung cancer diagnosis and treatment planning.
79 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products